Effects of morphine on brain plasticity;Efectos de la morfina en la plasticidad cerebral

Neurologia

Volumn 30, Issue 3, 2015, Pages 176-180

  Beltran Campos V ^a   Silva Vera, M ^a   Garcia Campos M L ^a   Diaz Cintra S ^b  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b Instituto de Neurobiología   (Mexico)

Author keywords

Brain plasticity; Dendritic spines; Morphine; Opiate receptors

Indexed keywords

DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; MORPHINE; OPIATE RECEPTOR;

ADULT; AMYGDALOID NUCLEUS; BRAIN DEVELOPMENT; CAUDATE NUCLEUS; DENDRITE; DENDRITIC SPINE; HIPPOCAMPUS; HUMAN; LIMBIC SYSTEM; NERVE CELL PLASTICITY; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PAIN; PREFRONTAL CORTEX; PRENATAL PERIOD; SHORT SURVEY; TERMINALLY ILL PATIENT; AMYGDALA; ANIMAL; BRAIN; DRUG EFFECTS;

AMYGDALA; ANIMALS; BRAIN; DENDRITIC SPINES; HIPPOCAMPUS; HUMANS; MORPHINE; NEURONAL PLASTICITY; RECEPTORS, OPIOID;

EID: 84924971615     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2014.08.004     Document Type: Short Survey

References (43)

1. Oksanen A. Deleuze and the theory of addiction. J Psychoactive Drugs. 2013, 45:57-67.
2. LeBlanc K.H., Maidment N.T., Ostlund S.B. Repeated cocaine exposure facilitates the expression of incentive motivation and induces habitual control in rats. PLoS One. 2013, 8:e61355.
3. Robinson T.E., Berridge K.C. Review. The incentive sensitization theory of addiction: Some current issues. Philos Trans R Soc Lond B Biol Sci 2008, 363:3137-3146.
4. Dasgupta N., Kramer E.D., Zalman M.A., Carino S., Smith M.Y., Haddox J.D., et al. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend. 2006, 82:135-142.
5. Brownstein J.S., Green T.C., Cassidy T.A., Butler S.F. Geographic information systems and pharmacoepidemiology: Using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol Drug Saf. 2010, 19:627-637.
6. Morón J.A., Gullapalli S., Taylor C., Gupta A., Gomes I., Devi L.A. Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: Conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology. 2010, 35:955-966.
7. Back S.E., Payne R.A., Waldrop A.E., Smith A., Reeves S., Brady K.T. Prescription opioid aberrant behaviors: A pilot study of sex differences. Clin J Pain. 2009, 25:477-484.
8. Terenius L. From opiate pharmacology to opioid peptide physiology. Ups J Med Sci. 2000, 105:1-15.
9. De Gregori S., de Gregori M., Ranzani G.N., Allegri M., Minella C., Regazzi M. Morphine metabolism, transport and brain disposition. Metab Brain Dis. 2012, 27:1-5.
10. Mayer D.J., Liebeskind J.C. Pain reduction by focal electrical stimulation of the brain: An anatomical and behavioral analysis. Brain Res. 1974, 68:73-93.
11. Lord J.A., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides: Multiple agonists and receptors. Nature. 1977, 267:495-499.
12. Dreborg S., Sundström G., Larsson T.A., Larhammar D. Evolution of vertebrate opioid receptors. Proc Natl Acad Sci U S A. 2008, 105:15487-15492.
13. Inturrisi C.E. Clinical pharmacology of opioids for pain. Clin J Pain. 2002, 18(4 Suppl):S3-S13.
14. Volkow N.D., McLellan T.A., Cotto J.H., Karithanom M., Weiss S.R. Characteristics of opioid prescriptions in 2009. JAMA. 2011, 305:1299-1301.
15. Perez-Aguilar J.M., Xi J., Matsunaga F., Cui X., Selling B., Saven J.G., et al. A computationally designed water-soluble variant of a G-protein-coupled receptor: The human mu opioid receptor. PLoS One. 2013, 8:e66009.
16. He X., Sandhu H.K., Yang Y., Hua F., Belser N., Kim D.H., et al. Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events. Cell Mol Life Sci. 2013, 70:2291-2303.
17. Chao D., Xia Y. Ionic storm in hypoxic/ischemic stress: Can opioid receptors subside it?. Prog Neurobiol. 2010, 90:439-470.
18. Feng Y., He X., Yang Y., Chen J., Yin K., Xia Y. Effect of delta-opioid receptor over-expression on cortical expression of GABAA receptor alpha1-subunit in hypoxia. Chin J Physiol. 2011, 54:118-123.
19. Zhu M., Li M., Tian X., Ou X., Zhu C., Guo J. Neuroprotective role of delta-opioid receptors against mitochondrial respiratory chain injury. Brain Res. 2009, 1252:183-191.
20. Ma M.C., Qian H., Ghassemi F., Zhao P., Xia Y. Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: Novel insights into neuronal preconditioning and protection. J Biol Chem. 2005, 280:16208-16218.
21. Yang Y., Xia X., Zhang Y., Wang Q., Li L., Luo G., et al. δ-Opioid receptor activation attenuates oxidative injury in the ischemic rat brain. BMC Biol. 2009, 7:55.
22. Iwai T., Niwa M., Nakashima M., Kambara T., Yamada H., Tsurumi K., et al. Effect of opioids on delayed neuronal death in the gerbil hippocampus. Life Sci. 1992, 50:PL239-PL244.
23. Xia Y., Haddad G.G. Major difference in the expression of delta- and mu-opioid receptors between turtle and rat brain. J Comp Neurol. 2001, 436:202-210.
24. Nasiraei-Moghadam S., Sherafat M.A., Safari M.S., Moradi F., Ahmadiani A., Dargahi L. Reversal of prenatal morphine exposure-induced memory deficit in male but not female rats. J Mol Neurosci. 2013, 50:58-69.
25. Ferguson S.A., Ward W.L., Paule M.G., Hall R.W., Anand K.J. A pilot study of preemptive morphine analgesia in preterm neonates: Effects on head circumference, social behavior, and response latencies in early childhood. Neurotoxicol Teratol. 2012, 34:47-55.
26. De Graaf J., van Lingen R.A., Simons S.H., Anand K.J., Duivenvoorden H.J., Weisglas-Kuperus N., et al. Long-term effects of routine morphine infusion in mechanically ventilated neonates on children's functioning: Five-year follow-up of a randomized controlled trial. Pain. 2011, 152:1391-1397.
27. Bajic D., Commons K.G., Soriano S.G. Morphine-enhanced apoptosis in selective brain regions of neonatal rats. Int J Dev Neurosci. 2013, 31:258-266.
28. Miller E.C., Zhang L., Dummer B.W., Cariveau D.R., Loh H., Law P.Y., et al. Differential modulation of drug-induced structural and functional plasticity of dendritic spines. Mol Pharmacol. 2012, 82:333-343.
29. Meng M., Zhao X., Dang Y., Ma J., Li L., Gu S. Region-specific expression of brain-derived neurotrophic factor splice variants in morphine conditioned place preference in mice. Brain Res. 2013, 1519:53-62.
30. Wu X., Shi M., Wei C., Yang M., Liu Y., Liu Z., et al. Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal. J Neurosci Res. 2012, 90:1270-1283.
31. Takeuchi N., Oouchida Y., Izumi S.I. Motor control and neural plasticity through interhemispheric interactions. Neural Plast. 2012, 2012:823285.
32. Kalivas P.W., Volkow N.D. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry. 2011, 16:974-986.
33. Sheng M. Molecular organization of the postsynaptic specialization. Proc Natl Acad Sci U S A. 2001, 98:7058-7061.
34. Pal A., Das S. Chronic morphine exposure and its abstinence alters dendritic spine morphology and upregulates Shank1. Neurochem Int. 2013, 62:956-964.
35. Massa H., Lacoh C.M., Vutskits L. Effects of morphine on the differentiation and survival of developing pyramidal neurons during the brain growth spurt. Toxicol Sci. 2012, 130:168-179.
36. Katebi S.N., Razavi Y., Zeighamy Alamdary S., Khodagholi F., Haghparast A. Morphine could increase apoptotic factors in the nucleus accumbens and prefrontal cortex of rat brain's reward circuitry. Brain Res. 2013, 1540:1-8.
37. Attarian S., Tran L., Moore A., Stanton G., Meyer E., Moore R. The neurodevelopmental impact of neonatal morphine administration. Brain Sci. 2014, 4:321-334.
38. Tan J.W., Duan T.T., Zhou Q.X., Ding Z.Y., Jing L., Cao J., et al. Impaired contextual fear extinction and hippocampal synaptic plasticity in adult rats induced by prenatal morphine exposure. Addict Biol. 2014, 10.1111/adb.12158.
39. Li Y., Wang H., Niu L., Zhou Y. Chronic morphine exposure alters the dendritic morphology of pyramidal neurons in visual cortex of rats. Neurosci Lett. 2007, 418:227-231.
40. Pomierny-Chamioło L., Rup K., Pomierny B., Niedzielska E., Kalivas P.W., Filip M. Metabotropic glutamatergic receptors and their ligands in drug addiction. Pharmacol Ther. 2014, 142:281-305.
41. Money K.M., Stanwood G.D. Developmental origins of brain disorders: Roles for dopamine. Front Cell Neurosci. 2013, 7:260.
42. Cahill E., Salery M., Vanhoutte P., Caboche J. Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. Front Pharmacol. 2014, 4:172.
43. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology. 2004, 47(Suppl 1):33-46.